Oceania Healthcare Limited (NZSE:OCA) Stock Rockets 31% But Many Are Still Ignoring The Company
Jul 22
New Zealand (NZX) Healthcare Sector Analysis
UpdatedJul 26, 2024
DataAggregated Company Financials
Companies16
- 7D5.6%
- 3M13.7%
- 1Y9.8%
- YTD15.5%
In the last week, the Healthcare industry is up 5.6%, with Arvida Group up 57%. During this same period, the TruScreen Group underperformed, falling 5.3%. This takes the industry's 12 month performance to a gain of 9.8%. Earnings are forecast to grow by 18% annually.
Sector Valuation and Performance
Has the New Zealand Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 26 Jul 2024 | NZ$34.0b | NZ$17.7b | NZ$977.6m | 19.2x | 34.7x | 1.9x |
| Sun, 23 Jun 2024 | NZ$30.4b | NZ$17.4b | NZ$971.0m | 16.2x | 31.3x | 1.7x |
| Tue, 21 May 2024 | NZ$30.4b | NZ$17.4b | NZ$1.3b | 21.1x | 23.6x | 1.7x |
| Thu, 18 Apr 2024 | NZ$29.6b | NZ$17.3b | NZ$1.3b | 23.9x | 23.1x | 1.7x |
| Sat, 16 Mar 2024 | NZ$28.6b | NZ$17.2b | NZ$1.3b | 25.8x | 22.3x | 1.7x |
| Mon, 12 Feb 2024 | NZ$29.6b | NZ$16.4b | NZ$1.1b | 18.5x | 26.2x | 1.8x |
| Wed, 10 Jan 2024 | NZ$29.4b | NZ$16.7b | NZ$1.1b | 23.1x | 26x | 1.8x |
| Fri, 08 Dec 2023 | NZ$28.6b | NZ$16.5b | NZ$1.1b | 23.4x | 25.3x | 1.7x |
| Sun, 05 Nov 2023 | NZ$28.1b | NZ$16.6b | NZ$1.1b | 25.8x | 25.3x | 1.7x |
| Tue, 03 Oct 2023 | NZ$28.0b | NZ$16.4b | NZ$1.1b | 31x | 25.3x | 1.7x |
| Thu, 31 Aug 2023 | NZ$29.1b | NZ$16.5b | NZ$1.1b | 30.2x | 26.5x | 1.8x |
| Sat, 29 Jul 2023 | NZ$30.7b | NZ$15.8b | NZ$1.1b | 29.4x | 28.5x | 1.9x |
| Mon, 26 Jun 2023 | NZ$29.7b | NZ$15.9b | NZ$1.1b | 29.2x | 27.6x | 1.9x |
| Wed, 24 May 2023 | NZ$31.6b | NZ$15.3b | NZ$1.6b | 18.8x | 20x | 2.1x |
| Fri, 21 Apr 2023 | NZ$31.8b | NZ$15.7b | NZ$1.6b | 18.8x | 20.1x | 2x |
| Sun, 19 Mar 2023 | NZ$31.1b | NZ$15.5b | NZ$1.6b | 19x | 19.7x | 2x |
| Tue, 14 Feb 2023 | NZ$31.0b | NZ$14.8b | NZ$1.7b | 18.7x | 18.2x | 2.1x |
| Thu, 12 Jan 2023 | NZ$29.5b | NZ$14.7b | NZ$1.7b | 20x | 17.3x | 2x |
| Sat, 10 Dec 2022 | NZ$29.4b | NZ$14.4b | NZ$1.7b | 21.6x | 17.3x | 2x |
| Mon, 07 Nov 2022 | NZ$27.4b | NZ$14.9b | NZ$1.9b | 17.6x | 14.2x | 1.8x |
| Wed, 05 Oct 2022 | NZ$27.4b | NZ$15.4b | NZ$1.9b | 17x | 14.1x | 1.8x |
| Fri, 02 Sep 2022 | NZ$28.8b | NZ$15.2b | NZ$1.9b | 17.8x | 14.9x | 1.9x |
| Sun, 31 Jul 2022 | NZ$29.9b | NZ$14.0b | NZ$2.1b | 18.7x | 14.5x | 2.1x |
| Tue, 28 Jun 2022 | NZ$29.2b | NZ$13.9b | NZ$2.1b | 19.5x | 14.2x | 2.1x |
| Thu, 26 May 2022 | NZ$29.7b | NZ$14.2b | NZ$2.2b | 21.2x | 13.6x | 2.1x |
| Sat, 23 Apr 2022 | NZ$31.7b | NZ$14.1b | NZ$2.0b | 24.3x | 15.7x | 2.3x |
| Mon, 21 Mar 2022 | NZ$34.0b | NZ$13.8b | NZ$2.0b | 24.8x | 16.9x | 2.5x |
| Wed, 16 Feb 2022 | NZ$34.3b | NZ$13.2b | NZ$2.0b | 24.4x | 17.6x | 2.6x |
| Fri, 14 Jan 2022 | NZ$39.0b | NZ$13.1b | NZ$1.9b | 26.6x | 20x | 3x |
| Sun, 12 Dec 2021 | NZ$38.3b | NZ$13.0b | NZ$1.9b | 25.7x | 19.6x | 2.9x |
| Tue, 09 Nov 2021 | NZ$39.4b | NZ$12.8b | NZ$1.8b | n/a | 21.3x | 3.1x |
| Thu, 07 Oct 2021 | NZ$38.2b | NZ$12.9b | NZ$1.9b | 26.5x | 20.7x | 3x |
| Sat, 04 Sep 2021 | NZ$40.6b | NZ$13.0b | NZ$1.9b | 19.7x | 21.9x | 3.1x |
| Mon, 02 Aug 2021 | NZ$37.3b | NZ$13.0b | NZ$1.9b | 20.1x | 20.1x | 2.9x |
Price to Earnings Ratio
20.1x
Current Industry PE
- Investors are optimistic on the New Zealander Healthcare industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 34.7x which is higher than its 3-year average PE of 20.9x.
- The industry is trading close to its 3-year average PS ratio of 2.1x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have declined 19% per year over the last three years.
- Meanwhile revenues for these companies have grown 11% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the New Zealand Healthcare sector?
| NZ Market | 0.32% | |
| Healthcare | 5.58% | |
| Healthcare Services | 7.39% | |
| Medical Equipment | 4.36% | |
| Biotech | 2.38% | |
| Pharma | 0.69% | |
| Healthtech | 0% | |
| Life Sciences | 0% | |
Industry PE
- Investors are most optimistic about the Medical Equipment industry which is trading above its 3-year average PE ratio of 50.0x.
- Analysts are expecting annual earnings growth of 24.4%, which is higher than its past year's earnings decline of 47.0% per year.
Forecasted Growth
- Analysts are most optimistic on the Medical Equipment industry, expecting annual earnings growth of 24% over the next 5 years.
- This is better than its past earnings decline of 47% per year.
- In contrast, the Healthcare Services industry is expected to see its earnings grow by 8.7% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| ARV Arvida Group | NZ$1.62 | 57.3% +NZ$431.3m | 30.6% | PE8.5x | |
| FPH Fisher & Paykel Healthcare | NZ$32.22 | 1.8% +NZ$333.9m | 32.6% | PE142.3x | |
| RYM Ryman Healthcare | NZ$4.49 | 8.2% +NZ$233.0m | -33.9% | PE644.3x | |
| SUM Summerset Group Holdings | NZ$11.15 | 6.7% +NZ$164.7m | 8.4% | PE6x | |
| EBO EBOS Group | NZ$35.57 | 2.2% +NZ$150.7m | -7.0% | PE24x |
